CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
Titel:
CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
Auteur:
Lannutti, Brian J. Meadows, Sarah A. Herman, Sarah E.M. Kashishian, Adam Steiner, Bart Johnson, Amy J. Byrd, John C. Tyner, Jeffrey W. Loriaux, Marc M. Deininger, Mike Druker, Brian J. Puri, Kamal D. Ulrich, Roger G. Giese, Neill A.